Tower Research Capital (TRC)’s Sophiris Bio, Inc. SPHS Stock Holding History

Tower Research Capital (TRC)’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,395	Closed	-$2K	–	5563
2016 Q1	$2K	Buy	1,395 +954	+216%	+$1.68K	﹤0.01%	3594
2015 Q4	$1K	Buy	441 +341	+341%	+$505	﹤0.01%	4359
2015 Q3	$0	Hold	100	–	–	﹤0.01%	5638
2015 Q2	$0	Hold	100	–	–	﹤0.01%	5716
2015 Q1	$0	Hold	100	–	–	﹤0.01%	5582
2014 Q4	$0	Sell	100 -401	-80%	-$930	﹤0.01%	5534
2014 Q3	$1K	Buy	501 +401	+401%	+$1.13K	﹤0.01%	4327
2014 Q2	$0	Sell	100 -1,868	-95%	-$5.53K	﹤0.01%	5411
2014 Q1	$7K	Buy	1,968 +1,868	+1,868%	+$7.32K	﹤0.01%	3058
2013 Q4	$0	Buy	+100	New	+$423	﹤0.01%	5513

Other funds holding SPHS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Tower Research Capital (TRC)'s SPHS Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of Sophiris Bio, Inc. (SPHS) in Q2 2016, closing a stake of 1,395 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in SPHS in Q4 2013 and held it in 10 quarters. The position peaked at $7K in Q1 2014. 19 funds tracked by Wall St. Rank hold SPHS as of Q2 2016.

Tower Research Capital (TRC) reported no remaining Sophiris Bio, Inc. position as of Q2 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,395 Sophiris Bio, Inc. shares in Q2 2016, an estimated $2K.
Tower Research Capital (TRC) first reported a position in Sophiris Bio, Inc. in Q4 2013 and held it in 10 quarters.
Tower Research Capital (TRC)'s Sophiris Bio, Inc. position peaked at $7K in Q1 2014.
19 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.